Renaissance Group Opens New $35M Position in Halozyme Therapeutics (NASDAQ: HALO): Why This Biotech Stock Is Worth a Look ...
Frank Romanski of Lonza Capsugel dives into the excipient side of manufacturing and the emerging prevalence of digitalization ...
Tariffs increase operational costs by raising prices for raw materials, APIs, and finished drugs, complicating logistics and ...
Learn about Rani Therapeutics Holdings, Inc.’s innovative oral biologic drug delivery, current drug pipeline, and investment ...
Mallinckrodt Plc was sued in federal court Wednesday by a generic-drug maker that alleges the Irish pharmaceutical company breached sales contracts and monopolizes the market for pain pills containing ...
Dr. Lorraine Thorpe, DC, Founder of Thorpe Chiropractic and Wellness in St. Petersburg, Florida, joined Gayle Guyardo, host ...
Data from Storyful found that users’ fears around AI in the therapy space are widespread. The report noted that one user on Reddit called AI driven therapy a “control system,” while others warned of ...
NV-387 Could be the Answer to the MPox Clade I Rising in the USA, Says Dr. Diwan ...
Clever Culture is bringing automation to pharma microbiology, with its AI tech now used by global heavyweights such as ...
While investor enthusiasm often focuses on big tech, clinical-stage biotech Recursion Pharmaceuticals (NASDAQ: RXRX) is ...
The bidding war over biotechnology company Metsera (MTSR) has intensified, drawing fierce competition from pharmaceutical ...
Spencer Fano's impact on the Utah football team received national recognition Tuesday, as the standout offensive tackle was ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results